Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


18.03.2024

1 Aliment Pharmacol Ther
2 Am J Gastroenterol
2 BMC Gastroenterol
1 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
1 Gastroenterology
2 Gut
3 Inflamm Bowel Dis
3 J Crohns Colitis
1 Lancet


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. RICCIUTO A, Liu K, El-Matary W, Amin M, et al
    Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
    Aliment Pharmacol Ther. 2024 Mar 10. doi: 10.1111/apt.17936.
    PubMed         Abstract available


    Am J Gastroenterol

  2. KHAN N, Sundararajan R, Patel M, Trivedi C, et al
    Effectiveness Of Tofacitinib In Ulcerative Colitis Patients: A Nationwide Veterans Administration Cohort study.
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002761.
    PubMed         Abstract available

  3. DALAL RS, Kallumkal G, Cabral HJ, Barnes EL, et al
    One-Year Comparative Effectiveness of Upadacitinib Versus Tofacitinib For Ulcerative Colitis: A Multicenter Cohort Study.
    Am J Gastroenterol. 2024 Mar 12. doi: 10.14309/ajg.0000000000002746.
    PubMed         Abstract available


    BMC Gastroenterol

  4. BEHNOUSH AH, Maroufi SP, Reshadmanesh T, Mohtasham Kia Y, et al
    Circulatory resistin levels in inflammatory bowel disease: a systematic review and meta-analysis.
    BMC Gastroenterol. 2024;24:107.
    PubMed         Abstract available

  5. SHAO Y, Zhao Y, Lv H, Yan P, et al
    Clinical features of inflammatory bowel disease unclassified: a case-control study.
    BMC Gastroenterol. 2024;24:105.
    PubMed         Abstract available


    Dig Dis Sci

  6. SAHYOUN LC, Fetene J, McMillan C, Protiva P, et al
    Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08355.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  7. STEPHENS IJB, Murphy B, Burns L, McCawley N, et al
    Contemporary perioperative outcomes after total abdominal colectomy for ulcerative colitis in a tertiary referral centre.
    Eur J Gastroenterol Hepatol. 2024 Mar 11. doi: 10.1097/MEG.0000000000002755.
    PubMed         Abstract available

  8. ROKKAS T, Gisbert JP, Ekmektzoglou K, Dassopoulos T, et al
    Comparative maintenance performance of all biologic agents and small molecules in ulcerative colitis: a network meta-analysis.
    Eur J Gastroenterol Hepatol. 2024 Mar 12. doi: 10.1097/MEG.0000000000002751.
    PubMed         Abstract available

  9. FIORINO G, Colombel JF, Katsanos K, Mearin F, et al
    Iron therapy supplementation in inflammatory bowel disease patients with iron deficiency anemia: findings from a real-world analysis in Italy.
    Eur J Gastroenterol Hepatol. 2024 Mar 1. doi: 10.1097/MEG.0000000000002740.
    PubMed         Abstract available


    Gastroenterology

  10. IACUCCI M, Maeda Y, Ghosh S
    A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients with Ulcerative Colitis.
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00284.
    PubMed        


    Gut

  11. ANANTHAKRISHNAN AN
    Inflammatory bowel diseases: are we ready to recommend a preventive diet for infants?
    Gut. 2024;73:559-560.
    PubMed        

  12. SCHULZ-KUHNT A, Ruhle K, Javidmehr A, Dobronti M, et al
    ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo.
    Gut. 2024;73:601-612.
    PubMed         Abstract available


    Inflamm Bowel Dis


  13. Correction to: Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course.
    Inflamm Bowel Dis. 2024 Mar 14:izae070. doi: 10.1093.
    PubMed        

  14. ALSOUD D, Van Calster B
    Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Mar 9:izae048. doi: 10.1093.
    PubMed        

  15. SANDS BE, D'Haens G, Clemow DB, Irving PM, et al
    Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
    Inflamm Bowel Dis. 2024 Mar 9:izae024. doi: 10.1093.
    PubMed         Abstract available


    J Crohns Colitis

  16. GENG Z, Li J, Zuo L, Zhang X, et al
    Intestinal adipocytes transdifferentiate into myofibroblast-like cells and contribute to fibrosis in Crohn's disease.
    J Crohns Colitis. 2024 Mar 11:jjae036. doi: 10.1093.
    PubMed         Abstract available

  17. ZAMAN S, Mohamedahmed AYY, Abdelrahman W, Abdalla HE, et al
    Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques.
    J Crohns Colitis. 2024 Mar 11:jjae037. doi: 10.1093.
    PubMed         Abstract available

  18. LEHMANN M, Weixler B, Elezkurtaj S, Loddenkemper C, et al
    Spatial single cell profiling using imaging mass cytometry - inflammatory versus penetrating Crohn's disease.
    J Crohns Colitis. 2024 Mar 11:jjae033. doi: 10.1093.
    PubMed         Abstract available


    Lancet

  19. NIELSEN OH, Gubatan JM, Kolho KL, Streett SE, et al
    Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation.
    Lancet. 2024 Mar 5:S0140-6736(24)00052-7. doi: 10.1016/S0140-6736(24)00052.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.